The  ||| S:0 E:4 ||| DT
effect  ||| S:4 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
night  ||| S:14 E:20 ||| NN
vision  ||| S:20 E:27 ||| NN
goggles  ||| S:27 E:35 ||| NN
on  ||| S:35 E:38 ||| IN
the  ||| S:38 E:42 ||| DT
retinocortical  ||| S:42 E:57 ||| JJ
bioelectrical  ||| S:57 E:71 ||| JJ
activity  ||| S:71 E:80 ||| NN
and  ||| S:80 E:84 ||| CC
its  ||| S:84 E:88 ||| PRP$
improvement  ||| S:88 E:100 ||| NN
by  ||| S:100 E:103 ||| IN
food  ||| S:103 E:108 ||| NN
supplement  ||| S:108 E:119 ||| NN
To  ||| S:119 E:122 ||| TO
investigate  ||| S:122 E:134 ||| VB
the  ||| S:134 E:138 ||| DT
effect  ||| S:138 E:145 ||| NN
of  ||| S:145 E:148 ||| IN
luminance  ||| S:148 E:158 ||| JJ
variations ||| S:158 E:168 ||| NNS
,  ||| S:168 E:170 ||| ,
as  ||| S:170 E:173 ||| RB
well  ||| S:173 E:178 ||| RB
as  ||| S:178 E:181 ||| IN
the  ||| S:181 E:185 ||| DT
oral  ||| S:185 E:190 ||| JJ
administration  ||| S:190 E:205 ||| NN
of  ||| S:205 E:208 ||| IN
a  ||| S:208 E:210 ||| DT
food  ||| S:210 E:215 ||| NN
supplement ||| S:215 E:225 ||| NN
,  ||| S:225 E:227 ||| ,
on  ||| S:227 E:230 ||| IN
the  ||| S:230 E:234 ||| DT
visual  ||| S:234 E:241 ||| JJ
bioelectric  ||| S:241 E:253 ||| JJ
response  ||| S:253 E:262 ||| NN
while  ||| S:262 E:268 ||| IN
using  ||| S:268 E:274 ||| VBG
of  ||| S:274 E:277 ||| IN
Night  ||| S:277 E:283 ||| NNP
Vision  ||| S:283 E:290 ||| NNP
Goggles  ||| S:290 E:298 ||| NNP
( ||| S:298 E:299 ||| -LRB-
NVG ||| S:299 E:302 ||| NNP
) ||| S:302 E:303 ||| -RRB-
.  ||| S:303 E:305 ||| .
Two  ||| S:305 E:309 ||| CD
trials  ||| S:309 E:316 ||| NNS
were  ||| S:316 E:321 ||| VBD
performed ||| S:321 E:330 ||| VBN
,  ||| S:330 E:332 ||| ,
both  ||| S:332 E:337 ||| DT
enrolling  ||| S:337 E:347 ||| JJ
healthy  ||| S:347 E:355 ||| JJ
male  ||| S:355 E:360 ||| JJ
aircrew  ||| S:360 E:368 ||| JJ
members  ||| S:368 E:376 ||| NNS
wearing  ||| S:376 E:384 ||| VBG
NVG ||| S:384 E:387 ||| NNP
,  ||| S:387 E:389 ||| ,
and  ||| S:389 E:393 ||| CC
recording  ||| S:393 E:403 ||| VBG
Visual  ||| S:403 E:410 ||| NNP
Evoked  ||| S:410 E:417 ||| NNP
Potentials  ||| S:417 E:428 ||| NNP
( ||| S:428 E:429 ||| -LRB-
VEPs ||| S:429 E:433 ||| NNP
)  ||| S:433 E:435 ||| -RRB-
from  ||| S:435 E:440 ||| IN
scalp  ||| S:440 E:446 ||| JJ
electrodes ||| S:446 E:456 ||| NNS
.  ||| S:456 E:458 ||| .
Both  ||| S:458 E:463 ||| DT
foveal  ||| S:463 E:470 ||| NN
and  ||| S:470 E:474 ||| CC
parafoveal  ||| S:474 E:485 ||| JJ
response  ||| S:485 E:494 ||| NN
were  ||| S:494 E:499 ||| VBD
evaluated ||| S:499 E:508 ||| VBN
.  ||| S:508 E:510 ||| .
Latency  ||| S:510 E:518 ||| NNP
and  ||| S:518 E:522 ||| CC
amplitude ||| S:522 E:531 ||| NN
,  ||| S:531 E:533 ||| ,
P100  ||| S:533 E:538 ||| CD
peak ||| S:538 E:542 ||| NN
,  ||| S:542 E:544 ||| ,
were  ||| S:544 E:549 ||| VBD
measured ||| S:549 E:557 ||| VBN
.  ||| S:557 E:559 ||| .
In  ||| S:559 E:562 ||| IN
the  ||| S:562 E:566 ||| DT
first  ||| S:566 E:572 ||| JJ
set  ||| S:572 E:576 ||| NN
of  ||| S:576 E:579 ||| IN
measurements ||| S:579 E:591 ||| NNS
,  ||| S:591 E:593 ||| ,
VEPs  ||| S:593 E:598 ||| JJ
parameters  ||| S:598 E:609 ||| NNS
were  ||| S:609 E:614 ||| VBD
recorded  ||| S:614 E:623 ||| VBN
during  ||| S:623 E:630 ||| IN
unaided  ||| S:630 E:638 ||| JJ
photopic  ||| S:638 E:647 ||| JJ
conditions  ||| S:647 E:658 ||| NNS
and  ||| S:658 E:662 ||| CC
mesopic  ||| S:662 E:670 ||| JJ
conditions  ||| S:670 E:681 ||| NNS
while  ||| S:681 E:687 ||| IN
using  ||| S:687 E:693 ||| VBG
3rd  ||| S:693 E:697 ||| CD
generation  ||| S:697 E:708 ||| NN
plus  ||| S:708 E:713 ||| CC
NVG  ||| S:713 E:717 ||| NNP
( ||| S:717 E:718 ||| -LRB-
ANVIS  ||| S:718 E:724 ||| NNP
9 ||| S:724 E:725 ||| CD
) ||| S:725 E:726 ||| -RRB-
.  ||| S:726 E:728 ||| .
In  ||| S:728 E:731 ||| IN
the  ||| S:731 E:735 ||| DT
second  ||| S:735 E:742 ||| JJ
set  ||| S:742 E:746 ||| NN
of  ||| S:746 E:749 ||| IN
experiments ||| S:749 E:760 ||| NNS
,  ||| S:760 E:762 ||| ,
after  ||| S:762 E:768 ||| IN
the  ||| S:768 E:772 ||| DT
first  ||| S:772 E:778 ||| JJ
basal  ||| S:778 E:784 ||| JJ
electrophysiological  ||| S:784 E:805 ||| JJ
investigation  ||| S:805 E:819 ||| NN
during  ||| S:819 E:826 ||| IN
mesopic  ||| S:826 E:834 ||| JJ
conditions  ||| S:834 E:845 ||| NNS
using  ||| S:845 E:851 ||| VBG
NVG ||| S:851 E:854 ||| NNP
,  ||| S:854 E:856 ||| ,
patients  ||| S:856 E:865 ||| NNS
started  ||| S:865 E:873 ||| VBD
a  ||| S:873 E:875 ||| DT
45  ||| S:875 E:878 ||| CD
days  ||| S:878 E:883 ||| NNS
oral  ||| S:883 E:888 ||| JJ
treatment ||| S:888 E:897 ||| NN
,  ||| S:897 E:899 ||| ,
during  ||| S:899 E:906 ||| IN
which  ||| S:906 E:912 ||| WDT
they  ||| S:912 E:917 ||| PRP
took  ||| S:917 E:922 ||| VBD
3  ||| S:922 E:924 ||| CD
tablets  ||| S:924 E:932 ||| NNS
per  ||| S:932 E:936 ||| IN
day  ||| S:936 E:940 ||| NN
of  ||| S:940 E:943 ||| IN
a  ||| S:943 E:945 ||| DT
food  ||| S:945 E:950 ||| NN
supplement ||| S:950 E:960 ||| NN
.  ||| S:960 E:962 ||| .
The  ||| S:962 E:966 ||| DT
tablets  ||| S:966 E:974 ||| NNS
contained  ||| S:974 E:984 ||| VBD
a  ||| S:984 E:986 ||| DT
mix  ||| S:986 E:990 ||| NN
of  ||| S:990 E:993 ||| IN
anthocyanosides ||| S:993 E:1008 ||| NN
,  ||| S:1008 E:1010 ||| ,
procyanidolic  ||| S:1010 E:1024 ||| JJ
oligomers ||| S:1024 E:1033 ||| NN
,  ||| S:1033 E:1035 ||| ,
lutein  ||| S:1035 E:1042 ||| NN
and  ||| S:1042 E:1046 ||| CC
vitamins  ||| S:1046 E:1055 ||| JJ
A  ||| S:1055 E:1057 ||| NN
and  ||| S:1057 E:1061 ||| CC
E.  ||| S:1061 E:1064 ||| NNP
At  ||| S:1064 E:1067 ||| IN
the  ||| S:1067 E:1071 ||| DT
end  ||| S:1071 E:1075 ||| NN
of  ||| S:1075 E:1078 ||| IN
this  ||| S:1078 E:1083 ||| DT
treatment ||| S:1083 E:1092 ||| NN
,  ||| S:1092 E:1094 ||| ,
patients  ||| S:1094 E:1103 ||| NNS
were  ||| S:1103 E:1108 ||| VBD
tested  ||| S:1108 E:1115 ||| VBN
again  ||| S:1115 E:1121 ||| RB
by  ||| S:1121 E:1124 ||| IN
pattern-reversal  ||| S:1124 E:1141 ||| NNP
VEP  ||| S:1141 E:1145 ||| NNP
investigation  ||| S:1145 E:1159 ||| NN
during  ||| S:1159 E:1166 ||| IN
aided  ||| S:1166 E:1172 ||| JJ
vision  ||| S:1172 E:1179 ||| NN
condition  ||| S:1179 E:1189 ||| NN
( ||| S:1189 E:1190 ||| -LRB-
wearing  ||| S:1190 E:1198 ||| VBG
NVG ||| S:1198 E:1201 ||| NNP
)  ||| S:1201 E:1203 ||| -RRB-
in  ||| S:1203 E:1206 ||| IN
a  ||| S:1206 E:1208 ||| DT
mesopic  ||| S:1208 E:1216 ||| JJ
environment ||| S:1216 E:1227 ||| NN
.  ||| S:1227 E:1229 ||| .
VEPs  ||| S:1229 E:1234 ||| JJ
parameters ||| S:1234 E:1244 ||| NNS
,  ||| S:1244 E:1246 ||| ,
statistically  ||| S:1246 E:1260 ||| RB
evaluated  ||| S:1260 E:1270 ||| VBN
using  ||| S:1270 E:1276 ||| VBG
a  ||| S:1276 E:1278 ||| DT
two  ||| S:1278 E:1282 ||| CD
tailed  ||| S:1282 E:1289 ||| NNS
paired  ||| S:1289 E:1296 ||| VBN
t-test ||| S:1296 E:1302 ||| JJ
,  ||| S:1302 E:1304 ||| ,
showed  ||| S:1304 E:1311 ||| VBD
that  ||| S:1311 E:1316 ||| DT
latency  ||| S:1316 E:1324 ||| NN
and  ||| S:1324 E:1328 ||| CC
amplitude  ||| S:1328 E:1338 ||| NNS
were  ||| S:1338 E:1343 ||| VBD
respectively  ||| S:1343 E:1356 ||| RB
increased  ||| S:1356 E:1366 ||| VBN
( ||| S:1366 E:1367 ||| -LRB-
p  ||| S:1367 E:1369 ||| FW
< ||| S:1369 E:1371 ||| SYM
0.001  ||| S:1371 E:1377 ||| FW
and  ||| S:1377 E:1381 ||| CC
p  ||| S:1381 E:1383 ||| CD
< ||| S:1383 E:1385 ||| SYM
0.01  ||| S:1385 E:1390 ||| CD
for  ||| S:1390 E:1394 ||| IN
15 ||| S:1394 E:1396 ||| CD
'  ||| S:1396 E:1398 ||| ''
and  ||| S:1398 E:1402 ||| CC
60 ||| S:1402 E:1404 ||| NNP
'  ||| S:1404 E:1406 ||| POS
minutes  ||| S:1406 E:1414 ||| NNS
of  ||| S:1414 E:1417 ||| IN
arc ||| S:1417 E:1420 ||| CD
)  ||| S:1420 E:1422 ||| -RRB-
and  ||| S:1422 E:1426 ||| CC
decreased  ||| S:1426 E:1436 ||| VBD
( ||| S:1436 E:1437 ||| -LRB-
p  ||| S:1437 E:1439 ||| CD
< ||| S:1439 E:1441 ||| SYM
0.05 ||| S:1441 E:1445 ||| CD
)  ||| S:1445 E:1447 ||| -RRB-
when  ||| S:1447 E:1452 ||| WRB
measured  ||| S:1452 E:1461 ||| VBN
using  ||| S:1461 E:1467 ||| VBG
NVG  ||| S:1467 E:1471 ||| NNP
with  ||| S:1471 E:1476 ||| IN
respect  ||| S:1476 E:1484 ||| NN
to  ||| S:1484 E:1487 ||| TO
unaided  ||| S:1487 E:1495 ||| VB
basal  ||| S:1495 E:1501 ||| JJ
conditions ||| S:1501 E:1511 ||| NNS
.  ||| S:1511 E:1513 ||| .
Furthermore ||| S:1513 E:1524 ||| RB
,  ||| S:1524 E:1526 ||| ,
the  ||| S:1526 E:1530 ||| DT
VEP  ||| S:1530 E:1534 ||| NNP
response  ||| S:1534 E:1543 ||| NN
in  ||| S:1543 E:1546 ||| IN
NVG  ||| S:1546 E:1550 ||| NNP
aided  ||| S:1550 E:1556 ||| VBD
vision  ||| S:1556 E:1563 ||| NN
was  ||| S:1563 E:1567 ||| VBD
positively  ||| S:1567 E:1578 ||| RB
affected  ||| S:1578 E:1587 ||| VBN
by  ||| S:1587 E:1590 ||| IN
the  ||| S:1590 E:1594 ||| DT
oral  ||| S:1594 E:1599 ||| JJ
treatment  ||| S:1599 E:1609 ||| NN
with  ||| S:1609 E:1614 ||| IN
the  ||| S:1614 E:1618 ||| DT
food  ||| S:1618 E:1623 ||| NN
supplement ||| S:1623 E:1633 ||| NN
,  ||| S:1633 E:1635 ||| ,
showing  ||| S:1635 E:1643 ||| VBG
a  ||| S:1643 E:1645 ||| DT
significant  ||| S:1645 E:1657 ||| JJ
( ||| S:1657 E:1658 ||| -LRB-
p  ||| S:1658 E:1660 ||| CD
< ||| S:1660 E:1662 ||| SYM
0.05 ||| S:1662 E:1666 ||| CD
)  ||| S:1666 E:1668 ||| -RRB-
decrease  ||| S:1668 E:1677 ||| NN
of  ||| S:1677 E:1680 ||| IN
latency  ||| S:1680 E:1688 ||| NN
and  ||| S:1688 E:1692 ||| CC
increase  ||| S:1692 E:1701 ||| NN
of  ||| S:1701 E:1704 ||| IN
amplitude ||| S:1704 E:1713 ||| NN
.  ||| S:1713 E:1715 ||| .
The  ||| S:1715 E:1719 ||| DT
use  ||| S:1719 E:1723 ||| NN
of  ||| S:1723 E:1726 ||| IN
NVG  ||| S:1726 E:1730 ||| NNP
impairs  ||| S:1730 E:1738 ||| VBD
the  ||| S:1738 E:1742 ||| DT
VEP  ||| S:1742 E:1746 ||| NNP
response ||| S:1746 E:1754 ||| NN
,  ||| S:1754 E:1756 ||| ,
and  ||| S:1756 E:1760 ||| CC
such  ||| S:1760 E:1765 ||| JJ
effect  ||| S:1765 E:1772 ||| NN
is  ||| S:1772 E:1775 ||| VBZ
effectively  ||| S:1775 E:1787 ||| RB
counteracted  ||| S:1787 E:1800 ||| VBN
by  ||| S:1800 E:1803 ||| IN
the  ||| S:1803 E:1807 ||| DT
oral  ||| S:1807 E:1812 ||| JJ
treatment  ||| S:1812 E:1822 ||| NN
with  ||| S:1822 E:1827 ||| IN
a  ||| S:1827 E:1829 ||| DT
food  ||| S:1829 E:1834 ||| NN
supplement  ||| S:1834 E:1845 ||| NN
containing  ||| S:1845 E:1856 ||| VBG
a  ||| S:1856 E:1858 ||| DT
combination  ||| S:1858 E:1870 ||| NN
of  ||| S:1870 E:1873 ||| IN
sight  ||| S:1873 E:1879 ||| NN
improving  ||| S:1879 E:1889 ||| VBG
molecules  ||| S:1889 E:1899 ||| NNS
that  ||| S:1899 E:1904 ||| WDT
might  ||| S:1904 E:1910 ||| MD
enhance  ||| S:1910 E:1918 ||| VB
foveal  ||| S:1918 E:1925 ||| JJ
selectivity ||| S:1925 E:1936 ||| NN
,  ||| S:1936 E:1938 ||| ,
central  ||| S:1938 E:1946 ||| JJ
photoreceptors  ||| S:1946 E:1961 ||| JJ
sensitivity  ||| S:1961 E:1973 ||| NN
and  ||| S:1973 E:1977 ||| CC
magnocellular  ||| S:1977 E:1991 ||| JJ
fibers  ||| S:1991 E:1998 ||| NNS
effectiveness ||| S:1998 E:2011 ||| NN
.  ||| S:2011 E:2013 ||| .
